Previous studies have identified several variants of mutated EGFR in patients diagnosed with NSCLC, including EGFR exon 20 insertions, EGFR exon 19 deletions, and EGFR L858R point mutation in exon 21. Here, EGFR is linked to non-small cell lung carcinoma.